PDF 923kb

Financial Results for the 1st Half
Ended September 30, 2005
November 1, 2005
OMRON Corporation
Contents
1. Executive Summary
2. Results for the Six Months Ended September 30, 2005
3. Forecast for the Year Ending March 31, 2006
4. Supplementary explanation
5. Growth Strategy of Healthcare Business
Notes:
1. The financial statements are prepared in accordance with U.S. GAAP.
2. Includes 142 consolidated subsidiaries and 16 affiliated companies accounted for by the equity method.
3. Projections of results and future developments are based on information available to the Company at the
present time, as well as certain assumptions judged by the Company to be reasonable. Various factors could
cause actual results to differ materially from these projections. Major factors influencing Omron's actual results
include, but are not limited to, (i) the economic conditions surrounding the Company's businesses in Japan and
overseas, (ii) demand trends for the Company's products and services, (iii) the ability of the Omron Group
to develop new technologies and new products, (iv) major changes in the fund-raising environment, (v) tie-ups or
cooperative relationships with other companies, and (vi) movements in currency exchange rates and stock
markets.
2
Main Business Areas
Business
Business Name
Abbrev.
Business Description
Industrial Industrial Automation
Automation Business
IAB
Manufacture and sale of control
systems , equipment and components for
factory automation, etc.
Electronic Electronic Components
Components Business
ECB
Manufacture and sale of electronic
components for home appliances,
communications, mobile devices, etc.
Automotive
Electronics
Automotive Electronic
Components Business
AEC
Manufacture and sale of electronic
components for automobiles
Social
Systems
Social Systems Business
SSB
Manufacture, sale and services for
public transportation (automated
passenger gates, etc.) and traffic and
road management systems
Healthcare Business
HCB
Manufacture and sale of medical devices
(digital blood pressure monitors, etc.)
Others
Exploration of new businesses,
development businesses not included
in above
Healthcare
Equipment
Others
Business Development
Group/Others
3
Executive
Summary
1. Executive Summary
4
Executive
Summary
Executive Summary
The year ending March 31, 2006 is the 2nd year of Stage II (Apr. 2004 to March 2008) of Grand Design 2010 (GD2010)
“Achieving a robust profit structure” as a milestone toward the achievement of Stage II targets
1st Half Results and Key Points
・・Operating
Operatingincome/
income/Net
Netincome
incomebefore
beforetax
tax(NIBT)
(NIBT)both
bothexceeded
exceededthe
theoriginal
originalbudget
budgetand
andsame
sameperiod
periodprevious
previousyear,
year,
Net
sales
basically
as
planned
Net sales basically as planned
Consolidated
Result
vs.
vs.
Consolidated
Result
vs.original
originalbudget
budget
vs.same
sameperiod
periodininprev.
prev.year
year
Net
sales
¥285.4
billion
100.1%
94.4%
Net sales
¥285.4 billion
100.1%
94.4%
Operating
income
¥
31.3
billion
104.2%
100.2%
(Operating
Operating income ¥ 31.3 billion
104.2%
100.2%
(Operatingmargin
margin11.0%)
11.0%)
NIBT
¥
31.8
billion
105.9%
109.5%
(
NIBT
margin
11.1%)
NIBT
¥ 31.8 billion
105.9%
109.5%
( NIBT margin
11.1%)
----Main
factor
in
net
sales
decrease
was
ATM
business
to
Joint
Venture
(¥27.0
billion
decrease)
Main factor in net sales decrease was ATM business to Joint Venture (¥27.0 billion decrease)
----Despite
Despiteofoftransfer
transferofofATM
ATMbusiness
businesstotoJoint
JointVenture
Venture( (¥4.0
¥4.0billion
billionoperating
operatingincome
incomedecrease),
decrease),
operating
income
increased
due
to
return
of
substitutional
potion
of
pension
fund
operating income increased due to return of substitutional potion of pension fund
--Sales
--Salesby
bysegment
segmenthad
hadstrong
strongresults
resultsexcept
exceptfor
forElectronic
ElectronicComponents
ComponentsBusiness
Business(ECB)
(ECB)
Full-Year Forecasts and Key Points
・・Sales,
Sales,income
incomeboth
bothforecast
forecasttotobe
beininline
linewith
withthe
theinitial
initialbudget
budget
Year
ending
March
31,
2006
Year ending March 31, 2006
Net
sales
¥625.0
Net sales
¥625.0billion
billion (102.7%
(102.7%vs.
vs.prev.
prev.year)
year)
Operating
income
¥
65.0
billion
(115.8%
vs.
prev.
year)
Operating income ¥ 65.0 billion (115.8% vs. prev. year) Operating
Operatingmargin
margin 10.4%
10.4%
NIBT
¥
63.0
billion
(119.9%
vs.
prev.
year)
NIBT
margin
10.1%
NIBT
¥ 63.0 billion (119.9% vs. prev. year) NIBT margin
10.1%
5
Six Months ended
Sep. 30, 2005
2. Results for the Six Months Ended
September 30, 2005
6
Six Months ended
Sep. 30, 2005
Consolidated Income Statements
Net Sales ¥285.4B, Operating Margin 11.0%
Consolidated net sales, operating income both exceeded the original budget
Main factor in net sales decrease was SSB’s transfer of ATM business to Joint Venture
（billion yen)
Income Statement
6 months
ended
9/2004
Actual(1)
Net sales
Gross profit
SG&A expense
R&D expense
Operating income
NIBT
NIAT
6 months
ended
9/2005
Change from
last year
Actual(2)
302.3
127.3
71.9
24.2
---31.2
29.0
16.4
285.4
117.2
73.2
24.7
11.9
31.3
31.8
16.7
109.5
132.8
109.9
136.2
(2)/(1)
*
6 months
ended
9/2005
Change from
Original
budget
Original
budget(3)
(2)/(3)
94.4%
92.1%
101.7%
102.3%
---100.2%
109.5%
101.8%
285.0
117.0
71.0
25.0
9.0
30.0
30.0
17.0
0.4
3.4
100.0
130.0
Currency Rate
US$
EUR
100.1%
100.2%
103.1%
98.8%
132.4%
104.2%
105.9%
98.4%
(yen)
9.9
6.2
＊ 103.7% including sales of ATM business transferred to Joint Venture in October 2004.
7
Six Months ended
Sep. 30, 2005
Breakdown of Sales by Region and Business
Basically in line with budget in Japan and overseas
By segment, strong results except for ECB
（billion yen)
6 months
ended
9/2004
6 months
ended
9/2005
Change from
last year
By Region
Japan
Overseas**
Total
Actual(1)
181.0
121.3
302.3
Actual(2)
160.6
124.8
285.4
(2)/(1)
88.8%
102.8%
94.4%
Actual(1)
127.2
50.0
30.2
* 58.9
23.9
12.1
302.3
Actual(2)
130.3
45.9
35.1
34.0
27.6
12.5
285.4
(2)/(1)
102.4%
91.9%
116.3%
57.7%
115.3%
103.0%
94.4%
6 months
ended
9/2005
O riginal
budge t(3)
159.0
126.0
285.0
Change from
O riginal
budge t
(2)/(3)
101.0%
99.0%
100.1%
**Overseas includes direct exports
By Business
IAB
ECB
AEC
SSB
HCB
Ohters
Total
*Results for the year ended 3/2005 include an actual performance of the ATM business
O riginal
budge t(3)
131.0
51.0
34.0
32.0
26.0
11.0
285.0
(2)/(3)
99.4%
90.0%
103.3%
106.2%
106.0%
113.6%
100.1%
8
Six Months ended
Sep. 30, 2005
Breakdown of Operating Income By Segments
IAB exceeded
exceeded budget
budget due
due to
to expense
expense control
control
IAB
ECB faced
faced difficult
difficult conditions,
conditions, AEC
AEC continued
continued investments
investments
ECB
（billion yen)
6 months
ended
9/2004
6 months
ended
9/2005
Change from
last year
By Business
Actual(1)
Actual(2)
(2)/(1)
6 months
ended
9/2005
Change from
O riginal
budge t
O riginal
budge t(3)
(2)/(3)
IAB
23.6
20.4
86.5%
19.0
107.6%
ECB
8.3
5.3
64.1%
6.5
82.3%
AEC
-0.7
-0.8
----
0.5
----
3.7
-2.4
----
-2.5
----
HCB
3.0
3.1
102.2%
3.5
87.6%
Others
2.0
1.3
67.2%
1.0
134.4%
HQ Cost/Elimination
-8.7
-7.5
86.8%
-7.0
109.2%
----
11.9
----
9.0
132.4%
31.2
31.3
100.2%
30.0
104.2%
SSB
Total
＊
*Results for the year ended 3/2005 include an actual performance of ATM business
9
Six Months ended
Sep. 30, 2005
Breakdown of Changes in Operating Income
Despite of
of transfer
transfer of
of ATM
ATM business
business to
to Joint
Joint Venture,
Venture,
Despite
Operating income
income increased
increased due
due to
to return
return of
of aa substitutional
substitutional potion
potion of
of pension
pension
Operating
(transfer of ATM Business)
Exchange
Profit
Substitutional
potion of
（billion yen)
pension
Product mix
(excluding ATM Business)
+0.89
-4.05
-4.86
+3.06
Sales increase
(excluding ATM Business
and exchange profit)
Increase in
SG&A
expenses
-3.92
Increase in
R&D
expenses
-2.97
31.20
Change in
gross profit
-0.91
+11.91
31.26
Change in
SG&A expenses,
R&D expenses
-6.89
Change in operating income
+0.06
1st half FY2004
1st half FY2005
10
Six Months ended
Sep. 30, 2005
Segment Information
IAB (Industrial Automation Business)
Manufacture and sale of control systems and equipment for factory
automation and production machinery
Smart Sensor
Sensing Devices (Photoelectric/Proximity Sensors, AOI, etc.)
Control Devices (Programmable Logic Controllers, Relays, Timers, etc.)
Safety Devices (Safety sensors, Safety switches, etc.)
Net sales:
sales: ¥130.3b；
¥130.3b；
Operating margin:
margin: 15.7%
15.7%
Net
；； Operating
U.S., Asia
Asia remained
remained strong,
strong,
U.S.,
Greater China
China isis on
on aa gradual
gradual recovery
recovery trend
trend
Greater
Programmable Logic
Controller
（billion yen)
6 months
ended
9/2004
Actual(1)
IAB
6 months
ended
9/2005
Actual(2)
Change from
last year
(2)/(1)
6 months Change from
ended
Original
9/2005
budget
Original
budget(3)
(2)/(3)
Japan
65.7
65.2
99.3%
66.3
98.3%
Overseas
61.5
65.1
105.8%
64.7
100.6%
10.1
11.4
112.5%
10.3
110.8%
Europe
32.4
33.2
102.5%
34.5
96.2%
Asia
5.6
6.2
109.6%
5.8
106.2%
China
11.3
12.1
106.9%
12.0
100.6%
Exports
2.1
2.2
106.9%
2.1
106.9%
127.2
130.3
102.4%
131.0
99.4%
23.6
20.4
86.5%
19.0
107.6%
North America
Total
Operating income
AOI (Automated Optical
Inspection System)
11
Six Months ended
Sep. 30, 2005
Segment Information
ECB (Electronic Components Business)
Manufacture and sale of electronic components for home appliances,
communications, mobile phones, amusement components, OA
ZD Connector
Relays, Switches, Connectors, Sensors, Micro Lens Arrays, Customized ICs, IC Coins,
Optical Communications Devices, etc.
Net sales:
sales: ¥45.9b；
¥45.9b；
Operating margin:
margin: 11.6%
11.6%
Net
；； Operating
Japan and
and overseas
overseas weak;
weak;
Japan
LCD Backlight
Backlight faced
faced difficult
difficult conditions
conditions
LCD
Relay, Switch
（billion yen)
6 months
ended
9/2004
Actual(1)
ECB
6 months
ended
9/2005
Actual(2)
Change from
last year
(2)/(1)
6 months Change from
ended
Original
9/2005
budget
Original
budget(3)
(2)/(3)
Japan
25.2
22.3
88.6%
24.5
91.2%
Overseas
24.8
23.6
95.3%
26.5
88.9%
5.2
4.7
90.3%
4.9
95.7%
Europe
5.9
6.1
103.2%
6.5
93.1%
Asia
2.8
2.9
103.7%
3.0
96.5%
China
5.7
6.1
106.5%
7.1
86.1%
Exports
5.2
3.8
74.1%
5.0
76.4%
50.0
45.9
91.9%
51.0
90.0%
8.3
5.3
64.1%
6.5
82.3%
North America
Total
Operating income
B-MLA
12
Six Months ended
Sep. 30, 2005
Segment Information
AEC (Automotive Electronic Components Business)
Automotive
Relay
Manufacture and sale of automotive electronic components
Automotive Relays, Sensors, Laser Radars, Power Window Switches,
Keyless Entry Systems, ECU, etc.
Net sales:
sales: ¥35.1b；
¥35.1b；
Operating income
income was
was negative
negative
Net
；； Operating
due to
to increasing
increasing cost
cost for
for production
production process
process improvement
improvement
due
Keyless Entry System
（billion yen)
AEC
6 months
ended
9/2004
Actual(1)
6 months
ended
9/2005
Actual(2)
Change from
last year
6 months Change from
ended
Original
9/2005
budget
Original
budget(3)
(2)/(3)
(2)/(1)
Japan
12.6
13.0
103.4%
13.5
96.5%
Overseas
17.6
22.1
125.5%
20.5
107.8%
10.1
12.5
123.8%
11.2
111.4%
Europe
2.1
3.0
143.0%
3.2
94.8%
Asia
5.3
6.6
124.4%
6.1
107.8%
China
0.0
0.0
0.0%
0.0
-
Exports
0.1
0.0
16.4%
0.0
-
Total
30.2
35.1
116.3%
34.0
103.3%
Operating income
-0.7
-0.8
-
0.5
-
North America
Automotive Laser Radar
13
Segment Information
SSB (Social Systems Business)
Six Months ended
Sep. 30, 2005
Manufacture and sale of equipment/modules, and provision of
solutions and services in the fields of public transportation
and traffic/road management
Automatic Gate
Public Transportation : Passenger Gates, Ticket Vending machines, etc.
Traffic/Road Management, Signal Controllers, Road Management Systems, etc.
Net sales：
sales：
¥34.0b
Net
：：¥34.0b
Net sales
sales exceeded
exceeded original
original budget,
budget,
Net
Operating income
income in
in line
line with
with budget
budget
Operating
Ticket Vending Machine
（billion yen)
6 months
ended
9/2004
Actual(1)
SSB
Japan
6 months
ended
9/2005
Actual(2)
Change from
last year
6 months Change from
ended
Original
9/2005
budget
Original
budget(3)
(2)/(3)
(2)/(1)
54.2
33.4
61.7%
30.9
108.2%
4.7
0.6
11.8%
1.1
50.5%
0.1
0.1
63.7%
0.6
15.5%
Europe
0.4
0.0
-
0.0
-
Asia
0.0
0.0
-
0.0
-
China
0.0
0.0
40.0%
0.0
-
Exports
4.3
0.5
10.8%
0.5
92.2%
58.9
34.0
57.7%
32.0
106.2%
3.7
-2.4
-
-2.5
-
Overseas
North America
Total
Operating income
Traffic/Road
Management System
*Results for the year ended 3/2005 include an actual performance of the ATM business. Net sales: ¥27b Operating income: ¥4b
107% YOY excluding ATM business in previous year
14
Segment Information
HCB (Healthcare Business)
Six Months ended
Sep. 30, 2005
Manufacture and sale of home and professional healthcare
equipment
Blood Pressure Monitor
Digital Blood Pressure Monitors, Digital Thermometers, Pedometers, Body Composition
Analyzers (Body-fat Analyzers), Electronic Pulse Massagers, Massage Chairs, etc.
Net sales：
sales：
¥27.6b；
Operating margin：
margin：
11.2%
Net
：：¥27.6b；
；； Operating
：：11.2%
Including sales
salesof
of CMT(COLIN
CMT(COLINMedical
Medical Technologies)
Technologies) since
since this
this July
July
Including
Body Composition Analyzer
（billion yen)
HCB
6 months
ended
9/2004
Actual(1)
6 months
ended
9/2005
Actual(2)
Change from
last year
(2)/(1)
6 months Change from
ended
Original
9/2005
budget
Original
budget(3)
(2)/(3)
Japan
11.4
14.3
125.3%
12.8
111.4%
Overseas
12.5
13.3
106.2%
13.2
100.7%
6.8
6.8
98.9%
7.1
95.1%
Europe
3.6
4.2
114.7%
3.7
113.2%
Asia
0.7
0.8
116.7%
0.8
105.8%
China
1.3
1.4
113.0%
1.5
94.1%
Exports
0.1
0.1
158.3%
0.1
95.0%
23.9
27.6
115.3%
26.0
106.0%
3.0
3.1
102.2%
3.5
87.6%
North America
Total
Operating income
Portable Electrocardiograph
15
Six Months ended
Sep. 30, 2005
Consolidated Balance Sheet
Return of
of aa substitutional
substitutional portion
portion of
of pension
pension fund
fund resulted
resulted in
in substantial
substantial decrease
decrease
Return
in accrued
accrued retirement
retirement benefit
benefit for
for employees
employees and
and increase
increase in
in Shareholders’
Shareholders’ equity
equity
in
Capital ratio
ratio (Shareholders’
(Shareholders’ equity
equity // Total
Total assets)
assets) :: 52.2%
52.2% to
to 64.6%
64.6%
Capital
(billion yen)
Consolidated B/S
Total Assets
Cash and cash equivalents
Notes and accounts receivable - trade
Inventories
Other current assets
Other assets
Total Liabilities
Bank Loans / Current portion of L/T debt
Long-term debt
Accrued retirement benefit for employees
Other liabilities
Shareholders' Equity
As of
9/30/2004
571.2
77.5
113.9
82.3
26.8
270.7
270.9
24.8
0.8
104.2
141.1
300.3
As of
3/31/2005
585.4
80.6
121.7
68.6
25.0
289.5
279.6
22.9
1.8
112.0
142.9
305.8
As of
9/30/2005
548.3
55.6
106.3
77.7
26.2
282.5
194.2
2.0
1.2
59.3
131.7
354.1
16
Six Months ended
Sep. 30, 2005
Consolidated Statements of Cash Flows
Increased cash-out
cash-out by
by ¥6.2b
¥6.2b for
for the
the 11stst half
half vs.
vs. same
same period
period in
in prev.
prev. year
year
Increased
due to
to investment
investment for
for future
future growth
growth and
and acquisitions
acquisitions
due
(billion yen)
Consolidated Statements of C/F
Net cash provided by operating activities
6 months
ended
9/2004
6 months
ended
9/2005
Year ended
3/2005
33.6
23.3
61.1
Net cash used in investing activities
-16.5
Free cash flow
Net cash used in financing activities
Effect of exchange rate changes
Net increase (decrease)
Cash and cash equivalents at end of the period
17.1
-37.3
2.6
-17.6
77.5
-22.7
0.6
-26.4
0.8
-25.0
55.6
-36.1
25.0
-40.7
1.3
-14.4
80.6
17
3. Forecast for the year Ending March 31, 2006
18
Year Ending
March 31, 2006
Full-year Forecast of Consolidated
Statements of Operations
Original
forecast
ofのSales
Profit
is not revised
売上高、
、利益の
見通しは
しは、
当初計画通り
り
売上高
利益
見通and
しは、
当初計画通
Statements of Income
(billion yen)
Year
ended
3/2005
Year
ending
3/2006
Change from
last year
Actual(1)
Forecasts(2)
(2)/(1)
Year
ending
3/2006
Original
budget(3)
Change from
Original
budget
(2)/(3)
Net Sales
608.6
625.0
102.7%
625.0
100.0%
Gross Profit
249.8
256.0
102.5%
256.0
100.0%
SG&A expenses
144.2
150.0
104.0%
150.0
100.0%
R&D expenses
49.4
50.0
101.1%
50.0
100.0%
Operating income
56.1
65.0
115.8%
65.0
100.0%
NIBT
52.5
63.0
119.9%
63.0
100.0%
NIAT
30.2
36.0
119.3%
36.0
100.0%
19
4. Supplementary explanation
20
Supplementary
explanation
Specific Factors influencing Operating Income
(1) Response to Regulated Chemicals
Response to hazardous chemical substance regulations (RoHS) will be
completed by the end of March, 2006. Progress on RoHS is in line with our
plan of the 1st half of FY 2005.
Cost of response to regulated chemicals
FY2004 ¥1.5 billion
FY2005 (Forecast) ¥4.3 billion
(billion yen)
6.0
5.0
3.1
4.0
4.3
3.0
1.2
2.0
1.0
FY2005
1.5
March, 2005 (result)
Sep, 2005 (result)
March, 2006 (estimate)
21
Specific Factors influencing Operating Income
(2) Return of a substitutional portion of pension fund
Supplementary
explanation
¥11.9b gained and PBO reduced due to return of a substitutional portion
of pension fund. Accrued retirement benefit reduced and Shareholders’ equity increased
on OMRON’s consolidated B/S
B/S of Pension
Fund
Reduction of benefit
obligation
Asset
*
PBO
Return of a
substitutional portion
PBO
Accrued retirement benefit
Accrued retirement benefit
Consolidated B/S
of OMRON
**
Accrued retirement benefit
Reduction of accrued
retirement benefit
Accrued retirement benefit
Increase of
Shareholders’ equity
Reduction of deferred tax
*PBO: Projected Benefit Obligation, 2.0% as discount rate
**Including accrued retirement benefit of non-OMRON Pension Fund
22
Progress of Key Strategic Themes
(1) Sales Growth in New Tech Fields
Supplementary
explanation
Sales performance in new tech fields is approx. ¥15b in the 1st half of FY2005
Accelerate our efforts toward the original plan in the 2nd half of FY2005
(billion yen)
90 Products;
80
70
AEC ：Laser radars for automobiles, etc.
ECB : MEMS Sensors, LCD BL, etc.
IAB : Automated Optical Inspection Machines, etc.
Others
60
50
156%
40
Result of 1st half
approx.¥15b
160% 28.8
30
20
45.0
Over ¥50b
increase
GD2010
Phase2 target:
¥68b
18.0
18.0
10
0
FY2003
FY2004
FY2005
FY2007
(Actual)
(Forecast)
(Target)
23
Progress of Key Strategic Themes
(2) Sales Growth in Greater China
Supplementary
explanation
Sales performance
in の
Grater
China isに
approx.
USD200m
in the 1stを
half
ofめる
FY2005
２００７年度
２００７年度の
目標達成に
目標達成
向け、
さらに成長率
さらに成長率を
高
年度
成長率
Accelerate our efforts toward the original plan in the 2nd half of FY2005
２００６年
２００６年３月期は
月期は中華圏での
中華圏での売上
での売上ＵＳ＄
売上ＵＳ＄５５１
ＵＳ＄５５１Ｍ
５５１Ｍを計画
(MUSD)
1,400
1330
1,200
1,000
Over ¥100b
(=USD 1b)
increase
800
551
600
+34%
412
400
200
325
246
201
+27%-
Result of 1st half
approx. USD200m
+32%
+22%
FY01
FY02
FY03
FY04 (Actual) FY05(Forecast)
FY07(Target)
24
5. Growth Strategy of Healthcare Business
Background on the acquisition of CMT (COLIN Medical Technology)
25
Growth Strategy
of Healthcare
Business
Medium-term Financial goals
Aiming for the realization of continued growth toward achieving
goals of GD2010 second stage
（
）
（billion
billion yen）
yen）
）
80
Sales
over 75.0
70
61.0
60
54.0
50.6
50
40
30
20
FY04
FY05
Original Plan
FY05
Plan of After
acquisition of CMT
FY07
Target including
CMT
26
Growth Strategy
of Healthcare
Business
Growth Strategy of Healthcare Business
Focus on “primary / secondary preventive medical care
for lifestyle disease”
Professionals
Primary / secondary
preventive medical care
for lifestyle disease
Medical treatment
-Hospital room monitors
-Operating room monitors
- Vascular screening devices
- Blood pressure monitors
- ECG
Consumers
- Body composition (fat) meters
- Pedometers
Growth by the synergy
between OMRON and CMT
Existing business area of
OMRON Healthcare
Health promotion
Home
Expansion of operating base
by acquisition of CMT
Medical institutions
Create a new market by
(1) Developing “easy-to-use” consumer medical devices based on long-term clinical data
(2) Expanding networks with medical institutions and nurture “trust”
(3) Developing a new business model to efficiently implement preventive medical care
27
Growth Strategy
of Healthcare
Business
Purpose of the acquisition of CMT
Acquisition of CMT:
Strengthen professional medical device business
Main
Main product
product lines
lines
Market
Market share
share (Japan)
(Japan)
inpatient blood pressure
monitoring devices
Vital signs monitors
Market size
1
2
3
10.1 bn yen
Nihon
Koden
(54%)
Fukuda
Denshi
(28%)
CMT
(13%）
）
Operating room
monitors
3.8 bn yen
CMT
(31%)
Philips
(31%)
Nihon
Koden
(13%)
Vascular screening
devices
1.9 bn yen
CMT
(55%)
Fukuda
Denshi
(44%)
Nihon
Koden (1%)
1.5 bn yen
CMT
(34%)
elk
(33%)
A&D
(10%)
Hospital room
monitors
Operating
Operating
room
room
Exhaled
gas monitors
Full-automatic blood
pressure monitors
Hospital
Hospital
room
room
Medical
Medical
examination
examination
Central monitors
Vascular screening
devices
Market share 1
Sales breakdown
breakdown by
by business
business segment
segment （
（FY04）
FY04）
）
Sales
）
Overseas business
27%
Full-automatic blood
pressure monitors
Operating room monitors
18%
1
Repair and maintenance
18%
Hospital room monitors
16%
Vascular screening devices
Full-automatic blood
12%
pressure monitors, etc.
9% Total：
：8.6 bn yen
Based on 2004 sales figures
Colin Medical Technology (CMT), a leader of professional
medical devices in Japan
28
Growth Strategy
of Healthcare
Business
Synergy from the acquisition of CMT
OMRON Healthcare acquired technologies and products to measure / monitor blood
pressure and arteriosclerosis in hospitals
Cardiovascular monitors
Type of diseases
Situation
Operating room
Arteriosclerosis
Heart
Vital signs monitors
Hospital ward
Inpatient blood pressure
monitoring devices
Clinic
Full-automatic blood
pressure monitors
Examination room
Vital signs monitors
Medical checkup
Full-automatic blood
pressure monitors
Disease control
Blood pressure monitors
for management
Health control
Automatic blood pressure
monitors
Hospital
Medical
checkup
Blood pressure
CMT
products
Arteriosclerosis
monitoring devices
OMRON
products
Arteriosclerosis
monitoring devices
Portable electro
cardiographs
Home
29